Vaccine financing strategies: an industry perspective

  Vaccine research, innovation and distribution relies on funding. Does finance have too much influence on research, innovation and distribution decisions? Tell us below! Dr Clement Lewin, Head of Medical Affairs and Strategic Immunization Policy North America at Novartis joined us at the World Vaccine Congress 2012 in Washington to discuss vaccine financing strategies. The main objectives of his presentation …

#wvcusa – Daria Donati from GE Healthcare Life Sciences: #Vaccines: from self-sufficiency to market reach

  Dr Daria Donati presented today at the World Vaccine Congress in Washington about the vaccine market landscape and the role of emerging economies. There is a strong and growing global market in biologicals – demand doubled from 2006-2011.   New manufacturing approaches are needed that are tailored to the needs of emerging countries.  A key way to bring down costs …

#wvcusa Dr Mike McQuestion @SabinVaccineInstitute from paternalism to country ownership of national #immunization programs

  Dr Mike McQuestion presented today at the World Vaccine Congress in Washington about ownership of national immunization programs The Sabin Sustainable Immunization Financing Program works to create pathways to country ownership of immunization programs.  The group does advocacy work at high levels through parliamentary briefings, targeted peer exchanges and legislative workshops. Current investment needed to immunize a child in …